Analysis of mono-, di-, and triphosphates of thioguanosine and methylthioinosine in children with acute lymphoblastic leukemia by LC-MS/MS.

[1]  E. Takács,et al.  Beyond Chelation: EDTA Tightly Binds Taq DNA Polymerase, MutT and dUTPase and Directly Inhibits dNTPase Activity , 2019, Biomolecules.

[2]  J. Lim,et al.  Quantification of Thiopurine Nucleotides in Erythrocytes and Clinical Application to Pediatric Acute Lymphoblastic Leukemia , 2018, Therapeutic drug monitoring.

[3]  M. Peppelenbosch,et al.  Analytical and Sample Preparation Protocol for Therapeutic Drug Monitoring of 12 Thiopurine Metabolites Related to Clinical Treatment of Inflammatory Bowel Disease , 2018, Molecules.

[4]  Yi-Jin Gao,et al.  Outcome of children with newly diagnosed acute lymphoblastic leukemia treated with CCLG‐ALL 2008: The first nation‐wide prospective multicenter study in China , 2018, American journal of hematology.

[5]  Z. Zhao,et al.  LC-MS/MS Analysis of Erythrocyte Thiopurine Nucleotides and Their Association With Genetic Variants in Patients With Neuromyelitis Optica Spectrum Disorders Taking Azathioprine , 2017, Therapeutic drug monitoring.

[6]  M. Hernández-Tejero,et al.  Mercaptopurine and inflammatory bowel disease: the other thiopurine. , 2016, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[7]  N. von Ahsen,et al.  Improved Method for Therapeutic Drug Monitoring of 6-Thioguanine Nucleotides and 6-Methylmercaptopurine in Whole-Blood by LC/MSMS Using Isotope-Labeled Internal Standards , 2013, Therapeutic drug monitoring.

[8]  S. Vikingsson,et al.  Monitoring of thiopurine metabolites - a high-performance liquid chromatography method for clinical use. , 2013, Journal of pharmaceutical and biomedical analysis.

[9]  U. Hofmann,et al.  Simultaneous quantification of eleven thiopurine nucleotides by liquid chromatography-tandem mass spectrometry. , 2012, Analytical chemistry.

[10]  Michael Wey,et al.  Insight into the 6-thiopurine-mediated termination of the invasive motility of tumor cells derived from inflammatory breast cancer. , 2011, Biochemistry.

[11]  M. Viana,et al.  Compliance with a protocol for acute lymphoblastic leukemia in childhood , 2011, Revista brasileira de hematologia e hemoterapia.

[12]  U. Hofmann,et al.  Determination of 6-Thioguanosine Diphosphate and Triphosphate and Nucleoside Diphosphate Kinase Activity in Erythrocytes: Novel Targets for Thiopurine Therapy? , 2010, Therapeutic drug monitoring.

[13]  K. Schmiegelow,et al.  Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia , 2010, Leukemia.

[14]  S. Vikingsson,et al.  Monitoring of Thiopurine Metabolites in Patients With Inflammatory Bowel Disease-What Is Actually Measured? , 2009, Therapeutic drug monitoring.

[15]  J. McElnay,et al.  Development and validation of an HPLC method for the rapid and simultaneous determination of 6-mercaptopurine and four of its metabolites in plasma and red blood cells. , 2009, Journal of pharmaceutical and biomedical analysis.

[16]  C. Der,et al.  Specificity and Mechanism of Action of EHT 1864, a Novel Small Molecule Inhibitor of Rac Family Small GTPases* , 2007, Journal of Biological Chemistry.

[17]  M. Neurath,et al.  Azathioprine Suppresses Ezrin-Radixin-Moesin-Dependent T Cell-APC Conjugation through Inhibition of Vav Guanosine Exchange Activity on Rac Proteins , 2006, The Journal of Immunology.

[18]  E. Seidman,et al.  Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine/6-mercaptopurine therapy. , 2005, Clinical chemistry.

[19]  U. Hofmann,et al.  6-thioguanosine diphosphate and triphosphate levels in red blood cells and response to azathioprine therapy in Crohn's disease. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[20]  P. Karran,et al.  Azathioprine and UVA Light Generate Mutagenic Oxidative DNA Damage , 2005, Science.

[21]  M. Neurath,et al.  CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. , 2003, The Journal of clinical investigation.

[22]  S. Targan,et al.  Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. , 2000, Gastroenterology.

[23]  V. Vasić,et al.  Prevention and recovery of CuSO4-induced inhibition of Na+/K+ -ATPase and Mg2+ -ATPase in rat brain synaptosomes by EDTA. , 1999, Toxicology letters.

[24]  J. Stobaugh,et al.  Determination of intracellular levels of 6-mercaptopurine metabolites in erythrocytes utilizing capillary electrophoresis with laser-induced fluorescence detection. , 1995, Analytical biochemistry.

[25]  R. D. De Abreu,et al.  6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts. , 1993, Biochemical pharmacology.